scorecardresearchAdvanced Enzyme Technologies Share Price Live NSE, BSE, Today - Advanced

Advanced Enzyme Technologies

BSE: 540025 | NSE: ADVENZYMES | ISIN: INE837H01020 | SECTOR: Biotechnology & Drugs

393.00 7.10 (1.84%)

26 Apr 2024, 09:59 (IST)
  • Open

    385.85
  • High

    393.00
  • Low

    385.40
  • Prev Close

    385.90
  • P/E

    -
  • Median P/E

    -
  • P/B

    -
  • Median P/B

    -
  • Market Cap

    43.95B
  • Volume

    9.32K
  • Vol. (20 day Avg.)

    0
  • PEG

    -
  • Div.Yield

    -
  • Bid

    391.50
  • Ask

    -

Company Description

  • Biotechnology & Drugs
  • BSE

    540025
  • NSE

    ADVENZYMES
  • ISIN

    INE837H01020

Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.

Company Officers

  • Beni Rauka

    Chief Financial Officer
  • Dipak Roda

    Senior Vice President - Business Development, Marketing
  • Mukund Kabra

    Whole Time Director
  • Martina Doering

    Managing Director and Head Of Business Development, evoxx technologies GmbH, Germany
  • Harshad Doshi

    Chief Financial Officer and Chief Operating Officer of the US subsidiaries
  • Michael Puls

    Managing Director and Head Of Research and Development, evoxx technologies GmbH, Germany
  • Sanjay Basantani

    Company Secretary, Head-Legal